USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Genome Sequencing Market By Type (Products and Services), By Technology (Polymerase Chain Reaction (PCR), Sanger Sequencing, Non-Sanger’s Sequencing, Microarray, and Next-Generation Sequencing (NGS)), By Application (Diagnostic, Research, and Others), By End-User (Healthcare Facilities & Diagnostic Centers, Research Institutes, and Pharmaceutical & Biotechnological Companies), And By Regions – Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 – 2026

Covid-19

Global Genome Sequencing Market Size, Share

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

[227+ Pages Report] According to Facts & Factors, the “Global Genome Sequencing Market” report clarifies the complete market overview and breakdown structure. In this report, the global genome sequencing market witnessed a value of USD 27 Billion by 2020 and with growth at a CAGR of 20% is projected to reach a value of USD 95 Billion by 2026.

logoMarket Overview

Genome sequencing is a technology that refers to the sequencing of the entire organism. This technique helps figure out the entire sequence or order of the DNA nucleotides/bases which includes the order of As, Cs, Gs, and Ts that form the backbone of an organism's DNA. In the human genome, there are around 3 billion genetic letters. The hi-end machines are used to read and sequence the genomes. Genome sequencing helps in the discovery of biomarkers, study of personalized medication, oncology studies, forensics, and others. In healthcare, there is a shift from conventional methods to precision medicines with the help of genomics. Currently, the most useful tool is whole-genome sequencing.

The rise in R&D activities and the increasing number of genome mapping programs across the globe are projected to propel the global genome sequencing market. The development of tools such as Neoantigen Presentation Score (NEOPS) is one of the major factors contributing to the industry growth.

logoIndustry Growth Factors

The growing demand for the prevention, treatment, and management of diseases is anticipated to boost the demand for genome sequencing over the forecast period. Additionally, the rising investments in research and advancements in the field of bioinformatics will further escalate market growth. The sudden onset of the COVID-19 pandemic has urged healthcare facilities, biotechnology companies, and the government to invest in research activities related to the development of vaccines or novel treatments. Moreover, the positive potentials of genome sequencing have encouraged start-ups to provide sequencing services for further application in genetic diseases, ancestry, and others.

The major factor contributing to the genome sequencing industry is the rising number of government genome projects such as the Personalized Medicine Programme, Saudi Human Genome Program, etc. The introduction of NGS has helped shift to personalized medicines and also reduce the cost of sequencing. However, the lack of awareness, high-costing tools, and shortage of skilled technicians are likely to hinder the genome sequencing market growth.

Genome Sequencing Market

logoSegmentation Analysis

The global genome sequencing market is segmented based on type, technology, application, end-user, and regions.

Based on type, the global genome sequencing market is divided into products and services. The product segment is projected to hold the largest market share over the forecast period. The growth is primarily due to the rising demand, utilization of consumables, and launch of new automated products & software. On the basis of technology, the market is categorized into polymerase chain reaction (PCR), Sanger sequencing, Non-Sanger’s sequencing, microarray, and next-generation sequencing (NGS). From these, the polymerase chain reaction (PCR) accounts for the largest market share in the global genome sequencing market due to its growing use and easy availability across the globe. By application, the genome sequencing market is classified into diagnostic, research, and others. The diagnostic segment accounts for the highest market share.

The dominance is majorly contributed to the rising use of NGS technology by clinical diagnostics and the rising demand for direct-to-consumer genetic testing. Additionally, the growing popularity of nutrigenomics for providing diet plans considering the diseases depending on the patients’ genes is likely to bolster the market growth over the forecast period. Based on end-user, the market is segmented into healthcare facilities & diagnostic centers, research institutes, and pharmaceutical & biotechnological companies. The research institutes segment is expected to dominate the global genome sequencing market due to the increasing government funding and support in the research field.

logo Report Scope

Report Attribute

Details

Market Size in 2020

USD 27 Billion

Projected Market Size in 2026

USD 95 Billion

CAGR Growth Rate

20% CAGR

Base Year

2020

Forecast Years

2021-2026

Key Market Players

Illumina, Inc., BGI, IntegraGen, Bio-Rad Laboratories, QIAGEN, Danaher, Pacific Biosciences of California, Inc., Oxford Nanopore Technologies, and Others

Key Segment

By Type, By Technology, By Application, By End-User, and Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

logo Regional Analysis

North America is expected to dominate the global genome sequencing market due to the increasing adoption of sequencing technologies and the growing demand for personalized medicines in this region. Moreover, the launch of Ancestryhealth, a next-generation sequencing technology to identify the blood disorder, colon cancer, breast cancer, and heart diseases related genes in this region will further propel the market over the forecast period. The Asia Pacific is anticipated to exhibit the highest growth rate due to the rising demand for sequencing and testing of genes in China.

logo Competitive Players

Some of the key players participating in the global genome sequencing market include Illumina, Inc., BGI, IntegraGen, Bio-Rad Laboratories, QIAGEN, Danaher, Pacific Biosciences of California, Inc., Oxford Nanopore Technologies, Genome Electric Company, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., and F. Hoffmann-La Roche Ltd., among others.

logo By Type Segment Analysis

  • Products
    • Instruments & Software
    • Consumables
  • Services

logo By Technology Segment Analysis

  • Polymerase Chain Reaction (PCR)
  • Sanger Sequencing
  • Non-Sanger’s Sequencing
  • Microarray
  • Next-Generation Sequencing (NGS)

logo By Application Segment Analysis

  • Diagnostic
  • Research
  • Others

logo By End-User Segment Analysis

  • Healthcare Facilities & Diagnostic Centers
  • Research Institutes
  • Pharmaceutical & Biotechnological Companies

logo By Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

Covid-19

Genome Sequencing Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • Illumina Inc.
  • BGI
  • IntegraGen
  • Bio-Rad Laboratories
  • QIAGEN
  • Danaher
  • Pacific Biosciences of California Inc.
  • Oxford Nanopore Technologies
  • Genome Electric Company
  • Agilent Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
     

Frequently Asked Questions

The factors propelling the growth of the global genome sequencing market include growing demand for the disease prevention, treatment, and management coupled with the development of new treatments and vaccines.
According to Facts & Factors, global demand for genome sequencing market is expected to generate revenue of around USD 95 Billion by end of 2026, growing at a CAGR of around 20% between 2021 and 2026.
North America is expected to hold the largest market share in global genome sequencing market due to the rising demand for sequencing technologies and personalized medicines in this region.
The key players dominating the global genome sequencing market include Illumina, Inc., BGI, IntegraGen, Bio-Rad Laboratories, QIAGEN, Danaher, Pacific Biosciences of California, Inc., Oxford Nanopore Technologies, Genome Electric Company, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., and F. Hoffmann-La Roche Ltd., among others.
why choose fnf
key questions answers

Related Reports

report img

Cryotherapy Units Market Report 2022 – 2028

[225+ Pages Report] According to Facts and Factors, the global cryotherapy unit market size was worth USD 361.4 million in 2021 and is estimated to grow to USD 487.08 million by 2028, with a compound annual growth rate (CAGR) of approximately 5.10% over the forecast period. The report analyzes the...

Published Date : 05-Aug-2022 | | Category : | Pages : 225 | Format : Read more

Inquiry for Buying Request Sample
report img

Cell Culture Media Market Report 2022 – 2028

[205+ Pages Report] According to Facts and Factors, the global cell culture media market size was worth around USD 4,716.20 million in 2021 and is estimated to grow to about USD 11,372.175 million by 2028, with a compound annual growth rate (CAGR) of approximately 15.80% over the forecast period. ...

Published Date : 05-Aug-2022 | | Category : | Pages : 205 | Format : Read more

Inquiry for Buying Request Sample